Type 2 diabetes trials in South Korea

In South Korea 64 Also abroad 1200

64 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Daegu, Daejeon, Gwangju, Gyeonggi-do, Incheon, Seongnam-si, Seoul
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Taking people
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Where
Daejeon, Gangwon-do, Gwangju, Gyeonggi-do, Seongnam-si, Seoul
Age
18 years and over
People
1,600 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00
Phase 3Taking people
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Where
Anyang-si, Daejeon, Incheon, Seoul, Yangsan
Age
18 years and over
People
954 worldwide
Run by
Pfizer
See details and how to joinNCT07595549 · EU 2026-525318-75-00
Phase 3Taking people
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
Where
Bucheon-si, Deagu, Junggu, Seongnam, Seoul
Age
10 years to 17 years
People
170 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Where
Ansan-si, Guri-si, Gwangju, Seongnam, Seoul
Age
18 years and over
People
1,035 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00
Phase 3Taking people
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Where
Ansan-si, Gwangju, Seongnam, Seoul
Age
18 years and over
People
1,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881458 · EU 2026-527230-31-00
Phase 3Not yet taking people in South Korea
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Where
Ansan-si, Busan, Guri-si, Gwangju, Gyeongsan-si, Junggu, Namdong-gu, Seogu, Seongnam, Seongnam-si, Seoul
Age
18 years and over
People
2,115 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00
Phase 3Not yet taking people in South Korea
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Where
Bucheon-si, Busan, Guri-si, Gwangju, Gyeongsan-si, Incheon, Seogu, Seongnam, Seoul, Ulsan, Wŏnju
Age
45 years to 64 years
People
3,000 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Where
Busan, Goyang-si, Guri-si, Gwangju, Gyeonggi-do, Seoul, Suwon, Yangsan
Age
18 years and over
People
2,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Anyang, Bucheon-si, Daegu, Seoul, Yangsan
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
Phase 3Taking people
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Where
Ansan-si, Bucheon-si, Busan, Daejeon, Daejoen, Gwangju, Incheon, Seongnam, Seoul, Suwon, Wŏnju
Age
18 years and over
People
11,800 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Where
Busan, Daegu, Daejeon, Incheon, Seoul, Suwon
Age
18 years and over
People
1,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784270
Phase 3Taking people
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Where
Busan, Changwon-si, Daegu, Daejeon, Guri-si, Incheon, Seoul
Age
18 years and over
People
1,200 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00
No phaseNot yet taking people in South Korea
Continuous Glucose Monitoring and Dietary Self-Management in Adults in Namwon
Where
Namwon
Age
40 years and over
People
860
Run by
Ji-Yeob Choi
See details and how to joinNCT07890740
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy
Where
Seoul
Age
19 years and over
People
276 worldwide
Run by
Boryung Pharmaceutical Co., Ltd
See details and how to joinNCT06220773
Phase 3Taking people
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Where
Busan, Daegu, Goyang-si, Gyeonggi-do, Incheon, Jongno-gu, Seoul, Suwon
Age
18 years and over
People
4,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07667803
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Where
Gwangju, Seoul
Age
18 years to 75 years
People
300 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07668388 · EU 2026-525465-42-00
No phaseTaking people
Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes
Where
Seongnam-si
Age
19 years and over
People
10,000
Run by
Chong Kun Dang Pharmaceutical
See details and how to joinNCT06838286
No phaseTaking people
AI-Based Phenome Data Analysis for Predicting the Onset of Major Diseases
Where
Seoul
Age
30 years to 65 years
People
1,000
Run by
Jae Yong Jeon, MD
See details and how to joinNCT07595718
Phase 3Taking people
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Where
Namdong-gu, Seogu, Seongnam, Seoul, Yangsan
Age
18 years and over
People
1,980 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00
Phase 2Taking people
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Where
Ansan-si, Seoul, Yangsan
Age
18 years to 75 years
People
270 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07415954 · EU 2025-523260-20-00
Phase 3Taking people
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
Where
Jongno-gu, Seongnam-si, Seoul
Age
18 years and over
People
800 worldwide
Run by
AstraZeneca
See details and how to joinNCT07662044 · EU 2025-523936-37-00
No phaseNot yet taking people in South Korea
Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes
Where
Hwaseong-si
Age
19 years and over
People
100
Run by
Dongtan Sacred Heart Hospital
See details and how to joinNCT07770737
No phaseNot yet taking people in South Korea
CGM-Based Glycemic Analysis After ESI
Where
Seoul
Age
20 years to 60 years
People
36
Run by
Korea University Anam Hospital
See details and how to joinNCT07280780
No phaseTaking people
Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
Where
Seoul
Age
20 years to 69 years
People
120
Run by
Korea University Anam Hospital
See details and how to joinNCT04284943